Access cutting-edge covid-19 treatment through this clinical trial at a research site in Detroit. Study-provided care at no cost to qualified participants.
Access covid-19 specialists in Detroit at no cost
This study follows strict safety protocols and ethical guidelines
All study-related covid-19 treatment provided free
The purpose for this study is to determine if the study drug baricitinib is effective and safe in hospitalized pediatric participants with Coronavirus disease 2019 (COVID -19) and to confirm the dose.
Sponsor: Eli Lilly and Company
Check if you qualify for this covid-19 clinical trial in Detroit, MI
If you're searching for covid-19 treatment options in Detroit, MI, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Detroit research site is actively enrolling participants for this clinical trial. You'll receive care from experienced covid-19 specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.